Why is Eli Lilly & Co. ?
- The company has declared positive results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 10,938.2 MM
- ROCE(HY) Highest at 86.7%
- DIVIDEND PER SHARE(HY) Highest at USD 3.52
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 26.80%, its profits have risen by 54.2% ; the PEG ratio of the company is 0.9
How much should you buy?
- Overall Portfolio exposure to Eli Lilly & Co. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Eli Lilly & Co. for you?
High Risk, Medium Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 16,813 MM
Highest at 101.35%
Highest at USD 3.9
The company hardly has any interest cost
Fallen by -0.34% (YoY
Highest at USD 17,181.5 MM
Lowest at 137.92 %
Highest at 3.9 times
Highest at USD 19,292 MM
Highest at USD 9,571.7 MM
Highest at USD 8,898.6 MM
Highest at USD 7,144.72 MM
Highest at USD 7.02
Lowest at 1.04 times
Lowest at 21.36%
Here's what is working for Eli Lilly & Co.
Operating Cash Flows (USD MM)
DPS (USD)
Net Sales (USD MM)
Net Sales (USD MM)
Operating Profit (USD MM)
Pre-Tax Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Cash and Cash Equivalents
Debt-Equity Ratio
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales
Depreciation (USD MM)
Here's what is not working for Eli Lilly & Co.
Inventory Turnover Ratio
DPR (%)






